<p>2025 年 9 月 10 日- 下午 11:54</p>
<p><strong>战略重塑以聚焦扩展的商业模式和增长战略。新的股票代码 “STEX”。</strong></p>
<p>洛杉矶和温哥华，2025 年 9 月 10 日（全球新闻稿）—— BioSig Technologies, Inc.（纳斯达克：BSGM）（“BioSig”）最近与 Streamex Exchange Corporation（“Streamex”）合并（统称为 “BSGM” 或 “公司”），今天宣布将于 2025 年 9 月 12 日东部时间凌晨 12:01 起更名为 Streamex Corp.。与更名相关，公司将把其交易符号更改为 “STEX”。公司的普通股将于 2025 年 9 月 12 日在纳斯达克资本市场以新名称和交易符号开始交易。</p>
<p>自 2025 年 9 月 12 日起，所有公司的股票交易、备案和市场相关信息将以新符号 “STEX” 报告。公司的 CUSIP 号码将保持不变，股东无需采取任何行动。公司的企业结构或运营的其他方面不会受到股票代码更改的影响。</p>
<p><strong>关于 Streamex Exchange Corporation</strong></p>
<p>Streamex 是一家真实世界资产（“RWA”）代币化公司，拥有机构级基础设施，将黄金和商品市场引入区块链。通过以黄金为基础的国库和推动现代商品市场的代币化技术实现。Streamex 是 BioSig Technologies, Inc.的全资子公司。</p>
<p><strong>关于 BioSig Technologies, Inc.</strong></p>
<p>BioSig Technologies, Inc.是一家医疗设备技术公司，拥有先进的数字信号处理技术平台——PURE EP™平台，为心脏电生理学家提供心血管心律失常消融治疗的洞察。</p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿包含 1995 年《私人证券诉讼改革法案》意义上的 “前瞻性声明”。此类声明可能以 “打算”、“可能”、“将”、“计划”、“期望”、“预期”、“项目”、“预测”、“估计”、“旨在”、“相信”、“希望”、“潜在” 或类似词语开头。前瞻性声明并不保证未来的表现，基于某些假设，并受到多种已知和未知的风险和不确定性的影响，其中许多超出我们的控制范围。我们的实际结果和财务状况可能与这些前瞻性声明中指示的预期结果和财务状况存在实质性差异，具体取决于我们是否能够实现收购 Streamex 的利益、是否获得股东对收购的批准，以及我们是否能够在收购及其他方面保持符合纳斯达克上市标准。有关其他风险和不确定性以及其他重要因素的讨论，任何可能导致我们的实际结果与前瞻性声明中包含的结果不同的因素，请参见我们向证券交易委员会提交的文件，包括 2025 年 4 月 15 日向 SEC 提交的 10-K 年度报告中的 “风险因素” 部分。除法律要求外，我们不承担公开更新或修订前瞻性声明的义务，除非有新信息、未来事件或其他情况。查看来源版本请访问 businesswire.com：https://www.businesswire.com/news/home/20250714401245/en/</p>
<p><strong>投资者关系联系人</strong></p>
<p>阿黛尔·凯里</p>
<p>Alliance Advisors 投资者关系</p>
<p>acarey@allianceadvisors.com</p>
<p>亨利·麦克菲</p>
<p>BioSig 首席执行官，Streamex 联合创始人</p>
<p>contact@Streamex.com</p>
<p>https://www.streamex.com/</p>
<p>https://x.com/streamex</p>
<p>来源：BioSig 和 Streamex</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVeU5qZzJNQ00zTVRRd05qSTBJekl3TVRnd056Zz0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVeU5qZzJNQ00zTVRRd05qSTBJekl3TVRnd056Zz0"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NDk4YWM3YmUtOTk2MS00ZTkyLThlYjItMjVjMjlkOTMwMzc4LTEwMjk2NDktMjAyNS0wOS0xMC1lbg==/tiny/BioSig-Technologies-Inc-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NDk4YWM3YmUtOTk2MS00ZTkyLThlYjItMjVjMjlkOTMwMzc4LTEwMjk2NDktMjAyNS0wOS0xMC1lbg==/tiny/BioSig-Technologies-Inc-.png"/></p>

BSGM

STEX

<p>BioSig Technologies, Inc. 将于 2025 年 9 月 12 日更名为 Streamex Corp.，此举是在与 Streamex Exchange Corporation 合并之后进行的。公司的交易代码将在纳斯达克资本市场更改为 "STEX"。此次战略性重 branding 旨在支持扩展的商业模式和增长战略，而 CUSIP 号码保持不变。此变更不会影响其他运营方面</p>

<p>09/10/2025 - 11:54 AM</p>
<div class="lb-trans"><p>2025 年 9 月 10 日- 下午 11:54</p>
</div><p><strong>Strategic Rebranding to Focus on Expanded Business Model and Growth Strategy. New Ticker Symbol “STEX”.</strong></p>
<div class="lb-trans"><p><strong>战略重塑以聚焦扩展的商业模式和增长战略。新的股票代码 “STEX”。</strong></p>
</div><p>LOS ANGELES &amp; VANCOUVER, British Columbia, Sept. 10, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig”), which recently merged with Streamex Exchange Corporation (“Streamex”) (together, “BSGM” or the “Company”),announced today that it will change its name to Streamex Corp., effective at 12:01 am Eastern Time on Friday, September 12, 2025. In connection with the name change, the Company will change its trading symbol to “STEX.” The Company’s common stock will commence trading on the Nasdaq Capital Market exchange under the new name and trading symbol on September 12, 2025.</p>
<div class="lb-trans"><p>洛杉矶和温哥华，2025 年 9 月 10 日（全球新闻稿）—— BioSig Technologies, Inc.（纳斯达克：BSGM）（“BioSig”）最近与 Streamex Exchange Corporation（“Streamex”）合并（统称为 “BSGM” 或 “公司”），今天宣布将于 2025 年 9 月 12 日东部时间凌晨 12:01 起更名为 Streamex Corp.。与更名相关，公司将把其交易符号更改为 “STEX”。公司的普通股将于 2025 年 9 月 12 日在纳斯达克资本市场以新名称和交易符号开始交易。</p>
</div><p>As of September 12, 2025, all Company stock trading, filings, and market related information will be reported under the new symbol “STEX”. The Company’s CUSIP number will remain unchanged, and no action is required from shareholders. No other aspects of the Company’s corporate structure or operations are impacted by the ticker symbol change.</p>
<div class="lb-trans"><p>自 2025 年 9 月 12 日起，所有公司的股票交易、备案和市场相关信息将以新符号 “STEX” 报告。公司的 CUSIP 号码将保持不变，股东无需采取任何行动。公司的企业结构或运营的其他方面不会受到股票代码更改的影响。</p>
</div><p><strong>About Streamex Exchange Corporation</strong></p>
<div class="lb-trans"><p><strong>关于 Streamex Exchange Corporation</strong></p>
</div><p>Streamex is a Real World Asset (“RWA”) tokenization company with Institutional grade infrastructure to bring the gold and commodities market on chain. Enabled by a gold denominated treasury and tokenization technology powering the modern commodities market. Streamex is a wholly owned subsidiary of BioSig Technologies, Inc.</p>
<div class="lb-trans"><p>Streamex 是一家真实世界资产（“RWA”）代币化公司，拥有机构级基础设施，将黄金和商品市场引入区块链。通过以黄金为基础的国库和推动现代商品市场的代币化技术实现。Streamex 是 BioSig Technologies, Inc.的全资子公司。</p>
</div><p><strong>About BioSig Technologies, Inc.</strong></p>
<div class="lb-trans"><p><strong>关于 BioSig Technologies, Inc.</strong></p>
</div><p>BioSig Technologies, Inc. is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP™ Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias.</p>
<div class="lb-trans"><p>BioSig Technologies, Inc.是一家医疗设备技术公司，拥有先进的数字信号处理技术平台——PURE EP™平台，为心脏电生理学家提供心血管心律失常消融治疗的洞察。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential,” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond our control. It is possible that our actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements, depending on factors including whether we will be able to realize the benefits of the acquisition of Streamex, whether shareholder approval of the acquisition will be obtained, and whether we will be able to maintain compliance with Nasdaq’s listing criteria in connection with the acquisition and otherwise. For a discussion of other risks and uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in forward-looking statements, see our filings with the Securities and Exchange Commission, including the section titled “Risk Factors” in our Annual Report on Form 10-K, filed with the SEC on April 15, 2025. We assume no obligation to publicly update or revise our forward-looking statements as a result of new information, future events or otherwise, except as required by law. View source version on businesswire.com:https://www.businesswire.com/news/home/20250714401245/en/</p>
<div class="lb-trans"><p>本新闻稿包含 1995 年《私人证券诉讼改革法案》意义上的 “前瞻性声明”。此类声明可能以 “打算”、“可能”、“将”、“计划”、“期望”、“预期”、“项目”、“预测”、“估计”、“旨在”、“相信”、“希望”、“潜在” 或类似词语开头。前瞻性声明并不保证未来的表现，基于某些假设，并受到多种已知和未知的风险和不确定性的影响，其中许多超出我们的控制范围。我们的实际结果和财务状况可能与这些前瞻性声明中指示的预期结果和财务状况存在实质性差异，具体取决于我们是否能够实现收购 Streamex 的利益、是否获得股东对收购的批准，以及我们是否能够在收购及其他方面保持符合纳斯达克上市标准。有关其他风险和不确定性以及其他重要因素的讨论，任何可能导致我们的实际结果与前瞻性声明中包含的结果不同的因素，请参见我们向证券交易委员会提交的文件，包括 2025 年 4 月 15 日向 SEC 提交的 10-K 年度报告中的 “风险因素” 部分。除法律要求外，我们不承担公开更新或修订前瞻性声明的义务，除非有新信息、未来事件或其他情况。查看来源版本请访问 businesswire.com：https://www.businesswire.com/news/home/20250714401245/en/</p>
</div><p><strong>Investor Relations Contact</strong></p>
<div class="lb-trans"><p><strong>投资者关系联系人</strong></p>
</div><p>Adele Carey</p>
<div class="lb-trans"><p>阿黛尔·凯里</p>
</div><p>Alliance Advisors Investor Relations</p>
<div class="lb-trans"><p>Alliance Advisors 投资者关系</p>
</div><p>acarey@allianceadvisors.com</p>
<div class="lb-trans"><p>acarey@allianceadvisors.com</p>
</div><p>Henry McPhie</p>
<div class="lb-trans"><p>亨利·麦克菲</p>
</div><p>CEO of BioSig, Co-Founder of Streamex</p>
<div class="lb-trans"><p>BioSig 首席执行官，Streamex 联合创始人</p>
</div><p>contact@Streamex.com</p>
<div class="lb-trans"><p>contact@Streamex.com</p>
</div><p>https://www.streamex.com/</p>
<div class="lb-trans"><p>https://www.streamex.com/</p>
</div><p>https://x.com/streamex</p>
<div class="lb-trans"><p>https://x.com/streamex</p>
</div><p>Source: BioSig and Streamex</p>
<div class="lb-trans"><p>来源：BioSig 和 Streamex</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVeU5qZzJNQ00zTVRRd05qSTBJekl3TVRnd056Zz0" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTUyNjg2MCM3MTQwNjI0IzIwMTgwNzg="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NDk4YWM3YmUtOTk2MS00ZTkyLThlYjItMjVjMjlkOTMwMzc4LTEwMjk2NDktMjAyNS0wOS0xMC1lbg==/tiny/BioSig-Technologies-Inc-.png" alt="" original-src="https://ml.globenewswire.com/media/NDk4YWM3YmUtOTk2MS00ZTkyLThlYjItMjVjMjlkOTMwMzc4LTEwMjk2NDktMjAyNS0wOS0xMC1lbg==/tiny/BioSig-Technologies-Inc-.png"/></p>

BioSig Technologies, Inc. 宣布公司更名为 Streamex Corp. | BSGM 股票新闻